SCHEMBL21949415

SCHEMBL21949415

Cn1c(=O)c(Nc2ccc(N3CCOCC3)cc2)nc2ccc(/C(C=N)=C/N)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGM P11217 7/20 0.43
CSNK2A1 P68400 1/20 0.42
FGFR1 P11362 1/20 0.40
SRC P12931 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
MAPT P10636 6/20 0.40
MAPK1 P28482 5/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TP53 P04637 2/20 0.39
AHR P35869 1/20 0.38
HTT P42858 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
KDR P35968 1/20 0.38
PTK2 Q05397 1/20 0.38
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21949405 0.92 PYGM (0.44) PYGMFGFR1SRCNPC1RAB9A
SCHEMBL21949135 0.90 PYGM (0.41) PYGMCSNK2A1
SCHEMBL21949448 0.89 SRC (0.41) FGFR1SRCIRAK4
SCHEMBL21949453 0.89 KMT2A (0.40) PYGMIRAK4MAPTMAPK1HTT
SCHEMBL21949125 0.89 PYGM (0.41) PYGMIRAK4MAPT
SCHEMBL21949426 0.89 MAPK9 (0.41) IRAK4MAPTMEN1KMT2APTK2
SCHEMBL21949412 0.88 HTT (0.42) PYGMIRAK4HTTKMT2ALMNA
SCHEMBL21949422 0.88 MAPK10 (0.41) PYGMIRAK4
SCHEMBL21949118 0.87 FGFR1 (0.41) PYGMCSNK2A1FGFR1SRCMAPT
SCHEMBL21949865 0.85 FGFR1 (0.44) CSNK2A1FGFR1SRCMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640247-B1 SYK INHIBITOR AND USE METHOD THEREFOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2022-01-12 EP disclosed
EP-3640247-A1 SYK INHIBITOR AND USE METHOD THEREFOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-04-22 EP disclosed